Assyro AI

FDA Orange Book · active-ingredient family

Ticlopidine hydrochloride

Ticlopidine hydrochloride is approved as 1 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:TICLID · NDA 019979

1

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
TICLID×2ROCHE PALONDA 019979Mar 24, 1993

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
TICLOPIDINE HYDROCHLORIDESUN PHARM INDS INCANDA 075526Sep 26, 2002
TICLOPIDINE HYDROCHLORIDEWATSON LABSANDA 075309Apr 26, 2000
TICLOPIDINE HYDROCHLORIDENATCO PHARMAANDA 075316Nov 02, 1999
TICLOPIDINE HYDROCHLORIDEMYLANANDA 075161Sep 13, 1999
TICLOPIDINE HYDROCHLORIDEACTAVIS ELIZABETHANDA 075253Aug 20, 1999
TICLOPIDINE HYDROCHLORIDECHARTWELL RXANDA 075318Aug 20, 1999
TICLOPIDINE HYDROCHLORIDECHARTWELL RXANDA 075326Aug 20, 1999
TICLOPIDINE HYDROCHLORIDETEVAANDA 075149Aug 20, 1999
TICLOPIDINE HYDROCHLORIDEAPOTEXANDA 075089Jul 01, 1999

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ticlopidine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.